288 related articles for article (PubMed ID: 9450927)
21. The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes.
Abdel-Malek ZA; Scott MC; Furumura M; Lamoreux ML; Ollmann M; Barsh GS; Hearing VJ
J Cell Sci; 2001 Mar; 114(Pt 5):1019-24. PubMed ID: 11181184
[TBL] [Abstract][Full Text] [Related]
22. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
[TBL] [Abstract][Full Text] [Related]
23. Inverse agonist activity of agouti and agouti-related protein.
Chai BX; Neubig RR; Millhauser GL; Thompson DA; Jackson PJ; Barsh GS; Dickinson CJ; Li JY; Lai YM; Gantz I
Peptides; 2003 Apr; 24(4):603-9. PubMed ID: 12860205
[TBL] [Abstract][Full Text] [Related]
24. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line.
Boston BA; Cone RD
Endocrinology; 1996 May; 137(5):2043-50. PubMed ID: 8612546
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and genetic studies of pigment-type switching.
Barsh G; Gunn T; He L; Schlossman S; Duke-Cohan J
Pigment Cell Res; 2000; 13 Suppl 8():48-53. PubMed ID: 11041357
[TBL] [Abstract][Full Text] [Related]
26. Melanocortins and their receptors and antagonists.
Voisey J; Carroll L; van Daal A
Curr Drug Targets; 2003 Oct; 4(7):586-97. PubMed ID: 14535656
[TBL] [Abstract][Full Text] [Related]
27. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
[TBL] [Abstract][Full Text] [Related]
28. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
[TBL] [Abstract][Full Text] [Related]
29. Syndecan-3 modulates food intake by interacting with the melanocortin/AgRP pathway.
Reizes O; Benoit SC; Strader AD; Clegg DJ; Akunuru S; Seeley RJ
Ann N Y Acad Sci; 2003 Jun; 994():66-73. PubMed ID: 12851299
[TBL] [Abstract][Full Text] [Related]
30. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation.
Cone RD; Lu D; Koppula S; Vage DI; Klungland H; Boston B; Chen W; Orth DN; Pouton C; Kesterson RA
Recent Prog Horm Res; 1996; 51():287-317; discussion 318. PubMed ID: 8701084
[TBL] [Abstract][Full Text] [Related]
31. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells.
Mountjoy KG; Kong PL; Taylor JA; Willard DH; Wilkison WO
Physiol Genomics; 2001 Feb; 5(1):11-9. PubMed ID: 11161002
[TBL] [Abstract][Full Text] [Related]
32. Novel agouti-related-protein-based melanocortin-1 receptor antagonist.
Thirumoorthy R; Holder JR; Bauzo RM; Richards NG; Edison AS; Haskell-Luevano C
J Med Chem; 2001 Nov; 44(24):4114-24. PubMed ID: 11708914
[TBL] [Abstract][Full Text] [Related]
33. Regulation of adipose tissue leptin secretion by alpha-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signalling system.
Hoggard N; Hunter L; Duncan JS; Rayner DV
J Mol Endocrinol; 2004 Feb; 32(1):145-53. PubMed ID: 14765998
[TBL] [Abstract][Full Text] [Related]
34. Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogenesis.
Hunt G; Thody AJ
J Endocrinol; 1995 Nov; 147(2):R1-4. PubMed ID: 7490543
[TBL] [Abstract][Full Text] [Related]
35. Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors.
Kim MS; Small CJ; Russell SH; Morgan DG; Abbott CR; alAhmed SH; Hay DL; Ghatei MA; Smith DM; Bloom SR
J Neuroendocrinol; 2002 Apr; 14(4):276-82. PubMed ID: 11963824
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor.
Yang Yk; Dickinson C; Haskell-Luevano C; Gantz I
J Biol Chem; 1997 Sep; 272(37):23000-10. PubMed ID: 9287296
[TBL] [Abstract][Full Text] [Related]
37. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells.
Hintermann E; Tanner H; Talke-Messerer C; Schlumberger S; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 2001 Feb; 21(1):93-116. PubMed ID: 11693176
[TBL] [Abstract][Full Text] [Related]
38. Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist.
Rouzaud F; Annereau JP; Valencia JC; Costin GE; Hearing VJ
FASEB J; 2003 Nov; 17(14):2154-6. PubMed ID: 14500544
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: antagonists for the AGRP/melanocortin receptor binding.
Arasasingham PN; Fotsch C; Ouyang X; Norman MH; Kelly MG; Stark KL; Karbon B; Hale C; Baumgartner JW; Zambrano M; Cheetham J; Tamayo NA
J Med Chem; 2003 Jan; 46(1):9-11. PubMed ID: 12502354
[TBL] [Abstract][Full Text] [Related]
40. Inverse agonism gains weight.
Adan RA; Kas MJ
Trends Pharmacol Sci; 2003 Jun; 24(6):315-21. PubMed ID: 12823958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
